Actively Recruiting
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
Led by Shengjing Hospital · Updated on 2026-02-27
600
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
How to construct a non-invasive, accurate, and convenient method to evaluate the severity of liver fibrosis (LF) is an important general problem in the management of patients with chronic hepatitis B (CHB). We plan to investigate the ability of magnetic resonance elastography (MRE) to grade fibrosis in chronic hepatitis B and apply to clinical longitudinal follow-up.
CONDITIONS
Official Title
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �38 years old
- Confirmed chronic hepatitis B using laboratory, imaging, and clinical tests
- MRE performed within 6 months before or after liver biopsy
- No previous treatment for chronic hepatitis B
- Child-Pugh Grade A liver function (score less than 7 points)
- Provided written informed consent for the prospective follow-up cohort
You will not qualify if you...
- Presence of liver malignant tumor
- Chronic hepatitis caused by other conditions such as alcoholic hepatitis
- Co-infection with hepatitis C, hepatitis D, or HIV
- Biliary tract diseases
- Contraindications or failure of MRE examination
- Poor quality of pathological results from biopsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shengjing Hospital
Shenyang, Liaoning, China, 210000
Actively Recruiting
Research Team
Y
Yiyang Wang
CONTACT
Y
Yu Shi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here